Company / PP&E (Net)
Tonix Pharmaceuticals Holding Corp. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$44.5M
FY2025
5-year range
$42.3M / $94.0M
FY2023-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $94M to $44M over the past 2 years.
Based on SEC 10-K filings.
$44M in FY2025.
Declined from $94M to $44M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e (net) increased 5.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.5M | +5.2% |
| FY2024 | $42.3M | -55.1% |
| FY2023 | $94.0M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026